FGFR3 and cancer: Similarly, inhibition of FGFR3 can induce cell cycle arrest and/or apoptosis in UC [8], [9] both in vitro and in vivo, providing validation that FGFR3 and downstream signaling pathways represent potentially relevant therapeutic targets for the treatment of FGFR3-associated cancers.